Back to jobs

In Vivo Operations Lead – Sr. Scientist II – Associate Director

South San Francisco

Company:

Addition Therapeutics is at the forefront of biotechnology innovation, advancing transformative therapies utilizing its proprietary PRINT™ (Precise RNA-mediated Insertion of Transgenes) platform. PRINT™ redefines genetic medicine by enabling development of RNA-only therapeutics capable of inserting any genetic element into specific safe harbor sites within the genome. Operating from state-of-the-art labs in South San Francisco, our team of experienced scientists and drug developers is leading scientific breakthroughs while cultivating a vibrant, dynamic culture committed to profoundly impacting patient lives.

Job description:

Addition Therapeutics is seeking a highly skilled and motivated Senior Scientist II / Associate Director to join our dynamic Preclinical Translation Team, focused on advancing our novel PRINT™ platform to the clinic.  The successful candidate will oversee the design, execution, and management of in vivo studies to support platform development and program advancement. This individual will direct and manage internal and external In Vivo Operations with a key focus on design and oversight of rodent and NHP studies at CROs. The ideal candidate will combine technical expertise, operational excellence, and strong leadership to ensure high-quality, reproducible, and compliant in vivo data generation.  They will be a highly collaborative and resourceful scientist with superior communication skills who can work on multiple projects in a fast-paced, matrixed setting.  This role has vast learning opportunities in the field of permanent gene insertion into the genome and presents a unique opportunity to explore the multifaceted applications of PRINT™, paving the way for novel therapeutic avenues/novel therapeutic programs and potential partnerships that could redefine the landscape of genetic medicine.

Key Responsibilities:

  • Design and manage execution of in vivo experiments to support target validation, platform development, and therapeutic programs.
  • Manage external studies with CROs, including vendor selection, protocol design, study oversight, data review, analysis, interpretation, and presentation to a wide audience.
  • Contribute to the design and oversight of NHP studies in collaboration with CROs and internal stakeholders.
  • Support design and execution of internal studies, including hands-on procedures such as dosing (IV, IP, SC), blood sampling, necropsy, and tissue collection.
  • Ensure compliance with IACUC and animal welfare regulations; draft and amend animal protocols as needed.
  • Maintain detailed and organized study records; contribute to study reports and presentations.
  • Collaborate closely with appropriate functional teams (research platform, program, bioanalytical, CMC and formulation) to align in vivo strategy and timelines with program objectives and deliverables.
  • Provide mentorship, training, and operational guidance to team members as appropriate.
  • Oversee histology sample management and contribute to building out in-house capabilities for IHC, ISH / RNAscope and digital pathology workflows.

Qualifications

  • M.S. or Ph.D. in Biology, Pharmacology, or related field with 8+ years of relevant industry experience
  • Title (Sr. Scientist II to Associate Director) commensurate with experience.
  • Strong track record of designing and executing in vivo studies including proficiency in analyzing and interpreting in vivo datasets and generating high-quality reports for internal and external stakeholders.
  • Extensive experience managing CROs, including rodent and NHP studies.
  • Proven hands-on expertise running in vivo studies in rodent models, including dosing, bleeds, necropsy, and tissue harvests.
  • Excellent organizational skills and meticulous attention to detail.
  • Outstanding communication skills and ability to work collaboratively across teams.
  • Nimble and adaptable in a fast-paced biotech environment.
  • Experience drafting and managing IACUC protocols required.
  • Preferred: Experience in liver, cardiometabolic, or oncology disease models.
  • Strong plus: Hands-on experience with histology workflows including handling, processing, and staining tissue samples for immunohistochemistry, RNAscope, etc. Experience building and running a histology core is highly desirable.
  • Team player who fosters a culture of collaboration, accountability, and scientific excellence, and who thrives in a fast-moving, results-oriented startup environment.
  • A self-motivated, driven individual with a passion to learn and can-do attitude.

Compensation

The expected annual salary range for this full-time position is $150,000-$210,000, plus eligibility for bonus, benefits, and equity incentives. Actual pay will be determined based on experience, qualifications, business needs, internal equity, and alignment with market data.

We are an Equal Opportunity employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status.

Create a Job Alert

Interested in building your career at Addition Therapeutics? Get future opportunities sent straight to your email.

Apply for this job

*

indicates a required field

Phone
Resume/CV*

Accepted file types: pdf, doc, docx, txt, rtf

Cover Letter

Accepted file types: pdf, doc, docx, txt, rtf


Education

Select...
Select...
Select...

Select...

(Proof of identity and eligibility will be required upon employment)

Select...
Select...

(If no, you may be required to provide authorization to work.)

Select...

[Please answer only if you have worked at Addition Therapeutics in the past]

[Please answer only if you have worked at Addition Therapeutics in the past]

[Please answer only if you have worked at Addition Therapeutics in the past]

Select...
Select...

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Addition Therapeutics’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Select...
Select...
Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Select...

Voluntary Self-Identification of Disability

Form CC-305
Page 1 of 1
OMB Control Number 1250-0005
Expires 04/30/2026

Why are you being asked to complete this form?

We are a federal contractor or subcontractor. The law requires us to provide equal employment opportunity to qualified people with disabilities. We have a goal of having at least 7% of our workers as people with disabilities. The law says we must measure our progress towards this goal. To do this, we must ask applicants and employees if they have a disability or have ever had one. People can become disabled, so we need to ask this question at least every five years.

Completing this form is voluntary, and we hope that you will choose to do so. Your answer is confidential. No one who makes hiring decisions will see it. Your decision to complete the form and your answer will not harm you in any way. If you want to learn more about the law or this form, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

How do you know if you have a disability?

A disability is a condition that substantially limits one or more of your “major life activities.” If you have or have ever had such a condition, you are a person with a disability. Disabilities include, but are not limited to:

  • Alcohol or other substance use disorder (not currently using drugs illegally)
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, HIV/AIDS
  • Blind or low vision
  • Cancer (past or present)
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or serious difficulty hearing
  • Diabetes
  • Disfigurement, for example, disfigurement caused by burns, wounds, accidents, or congenital disorders
  • Epilepsy or other seizure disorder
  • Gastrointestinal disorders, for example, Crohn's Disease, irritable bowel syndrome
  • Intellectual or developmental disability
  • Mental health conditions, for example, depression, bipolar disorder, anxiety disorder, schizophrenia, PTSD
  • Missing limbs or partially missing limbs
  • Mobility impairment, benefiting from the use of a wheelchair, scooter, walker, leg brace(s) and/or other supports
  • Nervous system condition, for example, migraine headaches, Parkinson’s disease, multiple sclerosis (MS)
  • Neurodivergence, for example, attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, dyslexia, dyspraxia, other learning disabilities
  • Partial or complete paralysis (any cause)
  • Pulmonary or respiratory conditions, for example, tuberculosis, asthma, emphysema
  • Short stature (dwarfism)
  • Traumatic brain injury
Select...

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.